Immunosenescence is a primary driver of the increased risk of cancer in older adults. An inactivated, nonpathogenic bacterium shows promise in stimulating T-cell production.
By John Leake
Courageous Discourse
July 16, 2026
Author's Note: This is the first in a series of articles about T-cell immunity and an immunotherapy for enhancing it.
The decline of T-cells with age-known as immunosenescence-is a primary driver of the increased risk of cancer in older adults.